Blue Jet Healthcare Ltd, incorporated in 1968 and the first manufacturer of saccharin and its salts (artificial sweeteners) in India, is engaged in pharmaceutical and healthcare ingredients and intermediates. The company reported a decline in profits for Q2FY26.
Financial Highlights:
- Revenues decreased 20.67% year-on-year to ₹165 crore from ₹208 crore.
- Total expenses fell 15.28% to ₹122 crore from ₹144 crore.
- Consolidated net profit declined 10.34% to ₹52 crore from ₹58 crore.
- Earnings per share dropped 10.42% to ₹3.01 from ₹3.36.
The profit decline was largely driven by a significant drop in revenues, partly offset by lower expenses.
Outlook:
Blue Jet Healthcare Ltd aims to stabilize revenues by focusing on product diversification and expanding its market reach to improve future profitability.
Explore the company’s past earnings and latest concall transcripts, click here to visit the AlphaStreet India News Channel.